다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
European journal of medicinal chemistry, v.125, 2017년, pp.1247 - 1267
Gregoric, T. , Sedic, M. , Grbcic, P. , Tomljenovic Paravic, A. , Kraljevic Pavelic, S. , Cetina, M. , Vianello, R. , Raic-Malic, S.
AI-Helper
Regioselective 1,4-disubstituted 1,2,3-triazole tethered pyrimidine-2,4-dione derivatives (5-23) were successfully prepared by the copper(I)-catalyzed click chemistry. While known palladium/copper-cocatalyzed method based on Sonogashira cross-coupling followed by the intramolecular 5-endo-dig ring c...
J. Clin. Jemal 57 43 2007 2007, CA Cancer
Eur. J. Med. Chem. Zhu 65 70 2013 10.1016/j.ejmech.2013.04.044 Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents
Eur. J. Med. Chem. Nepali 77 422 2014 10.1016/j.ejmech.2014.03.018 Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Expert Opin. Drug Discov. Gediya 4 1099 2009 10.1517/17460440903341705 Promise and challenges in drug discovery and development of hybrid anticancer drugs
Eur. J. Med. Chem. Pałasz 97 582 2015 10.1016/j.ejmech.2014.10.008 In search of uracil derivatives as bioactive agents. Uracils and fused uracils: synthesis, biological activity and applications
Eur. J. Med. Chem. Mohamed 69 591 2013 10.1016/j.ejmech.2013.08.032 Synthesis, antimicrobial, antioxidant activities of novel 6-aryl-5-cyano thiouracil derivatives
Chu 1993 Nucleosides and Nucleotides as Antitumor and Antiviral Agents
Godefridus 2006 Deoxynucleoside Analogs in Cancer Therapy
Chem. Rev. Ferrero 100 4319 2000 10.1021/cr000446y Biocatalytic selective modifications of conventional nucleosides, carbocyclic nucleosides, and C-Nucleosides
Townsend 1994 Chemistry of Nucleosides and Nucleotides
Lancet Oncol. Galmarini 3 415 2002 10.1016/S1470-2045(02)00788-X Nucleoside analogues and nucleobases in cancer treatment
Helv. Chim. Acta Martin-Kohler 87 956 2004 10.1002/hlca.200490089 Furo[2,3-d]pyrimidines and Oxazolo[5,4-d]pyrimidines as inhibitors of receptor tyrosine kinases (RTK)
J. Med. Chem. Peng 56 3889 2013 10.1021/jm400072p Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors,
Bioorg. Med. Chem. Lett. Zhang 24 3486 2014 10.1016/j.bmcl.2014.05.066 Five-membered heteroaromatic ring fused-pyrimidine derivatives: design, synthesis, and hedgehog signaling pathway inhibition study
J. Med. Chem. Shiao 56 5247 2013 10.1021/jm4006059 Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor
Bioorg. Med. Chem. Lett. Jiao 22 6212 2012 10.1016/j.bmcl.2012.08.020 Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors
Bioorg. Med. Chem. Zhao 19 3906 2011 10.1016/j.bmc.2011.05.038 Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold
J. Med. Chem. Gazivoda 50 4105 2007 10.1021/jm070324z Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4‘,5‘-didehydro-L-ascorbic acid derivatives
ACS Med. Chem. Lett. Me？i 6 1150 2015 10.1021/acsmedchemlett.5b00298 Discovery of new acid ceramidase-targeted acyclic 5-alkynyl and 5-heteroaryl uracil nucleosides
Nat. Rev. Cancer Ogretmen 4 604 2004 10.1038/nrc1411 Biologically active sphingolipids in cancer pathogenesis and treatment
J. Med. Chem. Pizzirani 56 3518 2013 10.1021/jm301879g Discovery of a new class of highly potent inhibitors of acid ceramidase: synthesis and structure-activity relationship (SAR)
Leukemia Bonhoure 22 971 2008 10.1038/leu.2008.95 Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells
Sci. Rep. Realini 3 1035 2013 10.1038/srep01035 Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
Chem. Rev. Chinchilla 107 874 2007 10.1021/cr050992x The Sonogashira reaction: A booming methodology in synthetic organic chemistry
Can. J. Chem. Janeba 88 628 2010 10.1139/V10-054 Synthesis and biological evaluation of acyclic nucleotide analogues with a furo[2,3-d]pyrimidin-2(3H)-one base
RSC Adv. Ang 4 4921 2014 10.1039/c3ra46010j Palladium-catalyzed annulation of internal alkynes in aqueous medium
J. Org. Chem. Mahendar 79 8566 2014 10.1021/jo501137q [Cu]-Catalyzed domino Sonogashira coupling followed by intramolecular 5-exo-dig cyclization: synthesis of 1,3-dihydro-2-benzofurans
Synlett Aucagne 2406 2004 Highly efficient AgNO3-catalyzed preparation of substituted furanopyrimidine-nucleosides
J. Org. Chem. Sniady 73 5881 2008 10.1021/jo8007995 Zinc-catalyzed cycloisomerizations. Synthesis of substituted furans and furopyrimidine nucleosides
Tetrahedron Lett. Fresneau 53 1760 2012 10.1016/j.tetlet.2012.01.106 One-pot Sonogashira-cyclization protocol to obtain substituted furopyrimidine nucleosides in aqueous conditions
Curr. Med. Chem. Rai-Mali 22 1462 2015 10.2174/0929867322666150227150127 Recent trends in 1,2,3-Triazolo-nucleosides as promising anti-infective and anticancer agents
Eur. J. Org. Chem. Safti 35 7695 2015 10.1002/ejoc.201501088 5-Triazolyluracils and their N1-sulfonyl derivatives: intriguing reactivity differences in the sulfonation of triazole N1′-substituted and N1′-unsubstituted uracil molecules
Today Kolb 8 1128 2003 The growing impact of click chemistry on drug discovery, Drug Discov
Bioorg. Med. Chem. Zhang 17 4873 2009 10.1016/j.bmc.2009.06.019 ‘Click’ D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity
J. Org. Chem. Jagasia 74 2964 2009 10.1021/jo802097m Peptide cyclization and cyclodimerization by CuI-mediated azide？alkyne cycloaddition
J. Med. Chem. Huber 52 6860 2009 10.1021/jm901120h 1,1′-disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands
Eur. J. Med. Chem. Głowacka 70 703 2013 10.1016/j.ejmech.2013.10.057 The synthesis, antiviral, cytostatic and cytotoxic evaluation of a new series of acyclonucleotide analogues with a 1,2,3-triazole linker
Eur. J. Med. Chem. Montagu 46 778 2011 10.1016/j.ejmech.2010.12.017 Synthesis of new C5-(1-substituted-1,2,3-triazol-4 or 5-yl)-2′-deoxyuridines and their antiviral evaluation
Bioorg. Med. Chem. Lett. Lee 19 4688 2009 10.1016/j.bmcl.2009.06.072 C5-Modified nucleosides exhibiting anticancer activity
Bioorg. Med. Chem. Lett. Park 20 5831 2010 10.1016/j.bmcl.2010.07.126 Design, synthesis, and anticancer activities of novel perfluoroalkyltriazole-appended 2'-deoxyuridines
Eur. J. Med. Chem. Yu 45 3219 2010 10.1016/j.ejmech.2010.03.038 Synthesis and antitumor activity of novel 2',3'-diethanethio-2',3',5'-trideoxy-5'-triazolonucleoside analogues
PLoS ONE Kumar 8 e70798 2013 10.1371/journal.pone.0070798 Phenyl 1,2,3-triazole-thymidine ligands stabilize G-Quadruplex DNA, inhibit DNA aynthesis and potentially reduce tumor cell proliferation over 3′-azido deoxythymidine
J. Med. Chem. Miyakoshi 55 6427 2012 10.1021/jm3004174 Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-dontaining uracil derivatives as potent human deoxyuridine triphosphatase inhibitors
Bioorg. Med. Chem. Marai 23 7448 2015 10.1016/j.bmc.2015.10.042 1,2,3-Triazole pharmacophore-based benzofused nitrogen/sulfur heterocycles with potential anti-Moraxella catarrhalis activity
Tetrahedron Lett. Kri？tafor 56 1222 2015 10.1016/j.tetlet.2015.01.152 One-pot click synthesis of 1,2,3-triazole-embedded unsaturated uracil derivatives and hybrids of 1,5- and 2,5-disubstituted tetrazoles and pyrimidines
Curr. Org. Chem. Korunda 17 1114 2013 10.2174/1385272811317100012 Conjugates of 1,2,3-Triazoles and acyclic pyrimidine nucleoside analogues: syntheses and X-ray crystallographic studies
J. Org. Chem. Batsanov 70 703 2005 10.1021/jo048428u Requirement for an oxidant in Pd/Cu Co-catalyzed terminal alkyne homocoupling to give symmetrical 1,4-disubstituted 1,3-diynes
Nat. Chem. Johnston 7 171 2015 10.1038/nchem.2150 Catalytic enantioselective synthesis of indanes by a cation-directed 5-endo-trig cyclization
Chem. Commun. Du 50 7437 2014 10.1039/c4cc03129f Copper-catalyzed 5-endo-trig cyclization of ketoxime carboxylates: a facile synthesis of 2-arylpyrroles
Chem. Commun. Alabugin 49 11246 2013 10.1039/c3cc43872d Finding the right path: Baldwin “Rules for Ring Closure” and stereoelectronic control of cyclizations
Kotora 973 2002 Handbook of Organopalladium Chemistry for Organic Synthesis
Siemsen vol. 39 2632 2000
Rev. Anal. Chem. Kocaoba 27 263 2008 10.1515/REVAC.2008.27.4.263 Potentiometric titration of some diamino compounds in toluene
Rev. Anal. Chem. Kocaoba 27 123 2008 10.1515/REVAC.2008.27.2.123 No-aqueous titrations: potentiometric titration of some primary amines
Acta Crystallogr. Allen B58 380 2002 10.1107/S0108768102003890 The Cambridge Structural Database: a quarter of a million crystal structures and rising
PLoS ONE Patil 10 e0125709 2015 10.1371/journal.pone.0125709 Pentacyclic triterpenoids inhibit IKKβ mediated activation of NF-κB pathway: in silico and in vitro evidences
Filimonov 182 2008 Chemoinformatics Approaches to Virtual Screening
Leukemia Weisberg 29 27 2015 10.1038/leu.2014.149 Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
BMC Cancer Hashimoto 19 292 2006 10.1186/1471-2407-6-292 Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line
J. Clin. Oncol. Leijen 28 3067 2010 10.1200/jco.2010.28.15_suppl.3067 A phase I pharmacological and pharmacodynamic study of MK-1775, a Wee1 tyrosine kinase inhibitor, in monotherapy and combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors
J. Clin. Oncol. Do 33 3409 2015 10.1200/JCO.2014.60.4009 Phase I Study of Single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumors
Clin. Cancer. Res. De Witt Hamer 17 4200 2011 10.1158/1078-0432.CCR-10-2537 WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe
J. Med. Chem. Palmer 49 4896 2006 10.1021/jm0512591 4-Phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione inhibitors of the checkpoint kinase Wee1. Structure-activity relationships for chromophore modification and phenyl ring substitution
PLoS One Kotelevets 7 e39209 2012 10.1371/journal.pone.0039209 Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis
Br. J. Pharmacol. Pastukhov 171 5829 2014 10.1111/bph.12886 The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
PLoS One Kogiso 9 e100495 2014 10.1371/journal.pone.0100495 Efficient induction of apoptosis by Wee1 kinase inhibition in hepatocellular carcinoma cells
Curr. Med. Chem. Amacher 12 1829 2005 10.2174/0929867054546663 Drug-associated mitochondrial toxicity and its detection
Toxicol. Sci. Marroquin 97 539 2007 10.1093/toxsci/kfm052 Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants
Diffraction 2012 Xcalibur CCD System
J. Appl. Crystallogr. Burla 38 381 2005 10.1107/S002188980403225X SIR2004: an improved tool for crystal structure determination and refinement
Acta Crystallogr. Sheldrick C71 3 2015 Crystal structure refinement with SHELXL
J. Appl. Crystallogr. Farrugia 45 849 2012 10.1107/S0021889812029111 WinGX and ORTEP for windows: an update
Acta Crystallogr. Spek D65 148 2009 Structure validation in chemical crystallography
J. Appl. Crystallogr. Macrae 41 466 2008 10.1107/S0021889807067908 Mercury CSD 2.0-new features for the visualization and investigation of crystal structures
Bioorg. Med. Chem. Gazivoda 16 5624 2008 10.1016/j.bmc.2008.03.074 Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues
Theor. Chim. Acta Andrae 77 123 1990 10.1007/BF01114537 Energy-adjusted ab initio pseudopotentials for the second and third row transition elements
Organometallics Sikk 30 5656 2011 10.1021/om2004817 Computational study of copper-free sonogashira cross-coupling reaction
ACS Catal. Garcia-Melchor 2 135 2012 10.1021/cs200526x Mechanistic exploration of the Pd-catalyzed copper-free Sonogashira reaction
J. Org. Chem. Picek 80 2165 2015 10.1021/jo5026755 Tandem β-elimination/hetero-Michael addition rearrangement of an N-alkylated pyridinium oxime to an O-alkylated pyridine oxime ether: an experimental and computational study
Chem. Res. Fukui 14 363 1981 10.1021/ar00072a001 The path of chemical reactions - the IRC approach Acc
Frisch 2009 GAUSSIAN 09 (Revision A.02)
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.